Founded in 1978 by Mr El GUERMAI Abdelghani, the GALENICA pharmaceutical laboratories develop, manufacture and provide generic medicines in compliance with international manufacturing standards. Based on these values ​​of EXCELLENCE, ETHICS and DYNAMISM, GALENICA now represents more than 50 brands, some of which enjoy a certain notoriety (NEOMOX, DIFAL, RHUMIX, CETAMYL), brings together more than 500 employees and is exported to more than 15 countries in Africa and the Middle East. GALENICA pharmaceutical laboratories ensure the quality of their production every day through the selection of these raw materials and compliance with the strictest standards. Thus, GALENICA guarantees the effectiveness and safety of its medicines, at the fairest possible cost, in order to meet patients' expectations. After having covered acute pathologies for a long time, GALENICA is now also involved in the treatment of chronic pathologies such as diabetes, cardiovascular pathologies and even pathologies of the central nervous system. Other challenges must also be met to enable the greatest number of patients to benefit from innovative, effective treatments against viral pathologies or even cancer, placing GALENICA in Moroccan national health programs and global health issues. Because the ultimate goal, our ultimate goal, the ultimate goal of GALENICA laboratories has always been and will remain the protection of everyone's health capital.